Related Experiment Video
Updated: Aug 1, 2026
11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Quinidine-induced hepatitis. A common and reversible hypersensitivity reaction
Archives of Internal Medicine
|March 1, 1986
Summary
Quinidine sulfate frequently causes drug-induced hepatitis, often presenting with fever preceding liver damage. This reversible reaction, characterized by hypersensitivity, resolves upon drug withdrawal and shows normal liver function long-term.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Toxicology
Background:
- Drug-induced liver injury (DILI) is a significant clinical concern.
- Identifying specific offending agents and their mechanisms is crucial for patient management.
Purpose of the Study:
- To identify the most common cause of drug-induced hepatitis over a decade.
- To analyze the clinical, laboratory, and histological features of quinidine-induced hepatitis.
- To assess the reversibility and long-term outcomes of quinidine-induced hepatitis.
Main Methods:
- Retrospective survey of drug-induced hepatitis cases over ten years.
- Analysis of clinical and laboratory data from 33 patients with quinidine-induced hepatitis.
- Review of liver biopsy histology.
- Long-term follow-up of 15 patients.
Main Results:
- Quinidine sulfate was identified as the most common cause of drug-induced hepatitis.
- Typical presentation includes fever preceding liver damage, often with gastrointestinal symptoms, rash, and thrombocytopenia, suggesting hypersensitivity.
- Histological findings revealed acute and chronic hepatitis with granulomas.
- Fifteen patients showed no liver function abnormalities upon long-term follow-up.
Conclusions:
- Quinidine-induced hepatitis is a recognizable and reversible drug reaction.
- Early recognition and discontinuation of quinidine are key to favorable outcomes.
- The hypersensitivity mechanism is supported by clinical and rechallenge data.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...